Comparison of Amiodarone with Combined Doses of Magnesium Sulphate and Lidocaine for Prevention of Ventricular Fibrillation Following Coronary Clamp Release During Coronary Artery Bypass Graft Surgery
Objective: To compare the effects of amiodarone with effects of combined doses of magnesium sulphate and lidocaine for prevention of ventricular fibrillation following coronary clamp release during (coronary artery bypass grafting) CABG. Study Design: Comparative cross sectional study. Place...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Army Medical College Rawalpindi
2022-11-01
|
| Series: | Pakistan Armed Forces Medical Journal |
| Subjects: | |
| Online Access: | https://pafmj.org/index.php/PAFMJ/article/view/9554 |
| _version_ | 1797938516855881728 |
|---|---|
| author | Muhammad Adnan Akram Mehwish Naseer Fakher-e- Fayaz Hana Khurshid Nasir Ali Imtiaz Ahmed Chaudhry |
| author_facet | Muhammad Adnan Akram Mehwish Naseer Fakher-e- Fayaz Hana Khurshid Nasir Ali Imtiaz Ahmed Chaudhry |
| author_sort | Muhammad Adnan Akram |
| collection | DOAJ |
| description |
Objective: To compare the effects of amiodarone with effects of combined doses of magnesium sulphate and lidocaine for prevention of ventricular fibrillation following coronary clamp release during (coronary artery bypass grafting) CABG.
Study Design: Comparative cross sectional study.
Place and Duration of Study: Army Cardiac Centre, Lahore Pakistan, from Jun 2021 to Dec 2021.
Methodology: One hundred patients who reported at Army Cardiac Centre Lahore, Pakistan for coronary artery bypass grafting surgery, were involved in comparative study. Patients satisfying the inclusion criteria were allocated into the LM(Lidocaine Magnesium) and A (Amiodarone) groups. Following aortic cross clamp release, the incidence of ventricular fibrillation (VF) and other arrhythmias was calculated in first 30 minutes and up to 24 hours later. The ionotropic agent used was epinephrine at a rate of 0.05 to 0.1 micrograms/kg/minute. Within 15 minutes of anesthetic induction and 15 minutes after the CPB pump was removed, hemodynamic parameters were assessed and recorded.
Results: Arrhythmias within 30 minutes and up to 24 hours after aortic cross clamp ACC release in A and LM group were compared. The difference between two groups, having arrhythmias and no arrhythmias was statistically insignificant (p≥0.050) except VF up to 24 hours after ACC release. The highest voltage for defibrillation was used in Group-A n=20 (40.0%) and n=27 (54.0%) in L.M group, (p=0.004). The average electrical defibrillations in group-A was less than that of group L.M,(p=0.000). While, the use of ionotropic agent was almost equal in both the groups, (p=0.975).
Conclusion: Overall, the amiodarone group had a decreased incidence of VF when the ACC was released, while the difference
was not statistically significant.
|
| first_indexed | 2024-04-10T19:00:55Z |
| format | Article |
| id | doaj.art-2a13847a99764996898cdbf096ec9356 |
| institution | Directory Open Access Journal |
| issn | 0030-9648 2411-8842 |
| language | English |
| last_indexed | 2024-04-10T19:00:55Z |
| publishDate | 2022-11-01 |
| publisher | Army Medical College Rawalpindi |
| record_format | Article |
| series | Pakistan Armed Forces Medical Journal |
| spelling | doaj.art-2a13847a99764996898cdbf096ec93562023-01-31T08:22:54ZengArmy Medical College RawalpindiPakistan Armed Forces Medical Journal0030-96482411-88422022-11-0172SUPPL-310.51253/pafmj.v72iSUPPL-3.9554Comparison of Amiodarone with Combined Doses of Magnesium Sulphate and Lidocaine for Prevention of Ventricular Fibrillation Following Coronary Clamp Release During Coronary Artery Bypass Graft SurgeryMuhammad Adnan Akram0Mehwish Naseer1Fakher-e- Fayaz2Hana Khurshid3Nasir Ali4Imtiaz Ahmed Chaudhry5Armed Forces Institute of Cardiology/National Institute of Heart Diseases/(AFIC/NIHD)/National University of Medical Sciences (NUMS) Rawalpindi PakistanArmy Cardiac Centre, Lahore, PakistanArmy Cardiac Centre, Lahore, PakistanHameed Latif Hospital, Lahore, PakistanArmed Forces Institute of Cardiology/National Institute of Heart Diseases/(AFIC/NIHD)/National University of Medical Sciences (NUMS) Rawalpindi PakistanArmed Forces Institute of Cardiology/National Institute of Heart Diseases/(AFIC/NIHD)/National University of Medical Sciences (NUMS) Rawalpindi Pakistan Objective: To compare the effects of amiodarone with effects of combined doses of magnesium sulphate and lidocaine for prevention of ventricular fibrillation following coronary clamp release during (coronary artery bypass grafting) CABG. Study Design: Comparative cross sectional study. Place and Duration of Study: Army Cardiac Centre, Lahore Pakistan, from Jun 2021 to Dec 2021. Methodology: One hundred patients who reported at Army Cardiac Centre Lahore, Pakistan for coronary artery bypass grafting surgery, were involved in comparative study. Patients satisfying the inclusion criteria were allocated into the LM(Lidocaine Magnesium) and A (Amiodarone) groups. Following aortic cross clamp release, the incidence of ventricular fibrillation (VF) and other arrhythmias was calculated in first 30 minutes and up to 24 hours later. The ionotropic agent used was epinephrine at a rate of 0.05 to 0.1 micrograms/kg/minute. Within 15 minutes of anesthetic induction and 15 minutes after the CPB pump was removed, hemodynamic parameters were assessed and recorded. Results: Arrhythmias within 30 minutes and up to 24 hours after aortic cross clamp ACC release in A and LM group were compared. The difference between two groups, having arrhythmias and no arrhythmias was statistically insignificant (p≥0.050) except VF up to 24 hours after ACC release. The highest voltage for defibrillation was used in Group-A n=20 (40.0%) and n=27 (54.0%) in L.M group, (p=0.004). The average electrical defibrillations in group-A was less than that of group L.M,(p=0.000). While, the use of ionotropic agent was almost equal in both the groups, (p=0.975). Conclusion: Overall, the amiodarone group had a decreased incidence of VF when the ACC was released, while the difference was not statistically significant. https://pafmj.org/index.php/PAFMJ/article/view/9554AmiodaroneArrhythmiasCardiopulmonary bypassCoronary artery bypass grafting (CABG)LidocaineMagnesium sulphate |
| spellingShingle | Muhammad Adnan Akram Mehwish Naseer Fakher-e- Fayaz Hana Khurshid Nasir Ali Imtiaz Ahmed Chaudhry Comparison of Amiodarone with Combined Doses of Magnesium Sulphate and Lidocaine for Prevention of Ventricular Fibrillation Following Coronary Clamp Release During Coronary Artery Bypass Graft Surgery Pakistan Armed Forces Medical Journal Amiodarone Arrhythmias Cardiopulmonary bypass Coronary artery bypass grafting (CABG) Lidocaine Magnesium sulphate |
| title | Comparison of Amiodarone with Combined Doses of Magnesium Sulphate and Lidocaine for Prevention of Ventricular Fibrillation Following Coronary Clamp Release During Coronary Artery Bypass Graft Surgery |
| title_full | Comparison of Amiodarone with Combined Doses of Magnesium Sulphate and Lidocaine for Prevention of Ventricular Fibrillation Following Coronary Clamp Release During Coronary Artery Bypass Graft Surgery |
| title_fullStr | Comparison of Amiodarone with Combined Doses of Magnesium Sulphate and Lidocaine for Prevention of Ventricular Fibrillation Following Coronary Clamp Release During Coronary Artery Bypass Graft Surgery |
| title_full_unstemmed | Comparison of Amiodarone with Combined Doses of Magnesium Sulphate and Lidocaine for Prevention of Ventricular Fibrillation Following Coronary Clamp Release During Coronary Artery Bypass Graft Surgery |
| title_short | Comparison of Amiodarone with Combined Doses of Magnesium Sulphate and Lidocaine for Prevention of Ventricular Fibrillation Following Coronary Clamp Release During Coronary Artery Bypass Graft Surgery |
| title_sort | comparison of amiodarone with combined doses of magnesium sulphate and lidocaine for prevention of ventricular fibrillation following coronary clamp release during coronary artery bypass graft surgery |
| topic | Amiodarone Arrhythmias Cardiopulmonary bypass Coronary artery bypass grafting (CABG) Lidocaine Magnesium sulphate |
| url | https://pafmj.org/index.php/PAFMJ/article/view/9554 |
| work_keys_str_mv | AT muhammadadnanakram comparisonofamiodaronewithcombineddosesofmagnesiumsulphateandlidocaineforpreventionofventricularfibrillationfollowingcoronaryclampreleaseduringcoronaryarterybypassgraftsurgery AT mehwishnaseer comparisonofamiodaronewithcombineddosesofmagnesiumsulphateandlidocaineforpreventionofventricularfibrillationfollowingcoronaryclampreleaseduringcoronaryarterybypassgraftsurgery AT fakherefayaz comparisonofamiodaronewithcombineddosesofmagnesiumsulphateandlidocaineforpreventionofventricularfibrillationfollowingcoronaryclampreleaseduringcoronaryarterybypassgraftsurgery AT hanakhurshid comparisonofamiodaronewithcombineddosesofmagnesiumsulphateandlidocaineforpreventionofventricularfibrillationfollowingcoronaryclampreleaseduringcoronaryarterybypassgraftsurgery AT nasirali comparisonofamiodaronewithcombineddosesofmagnesiumsulphateandlidocaineforpreventionofventricularfibrillationfollowingcoronaryclampreleaseduringcoronaryarterybypassgraftsurgery AT imtiazahmedchaudhry comparisonofamiodaronewithcombineddosesofmagnesiumsulphateandlidocaineforpreventionofventricularfibrillationfollowingcoronaryclampreleaseduringcoronaryarterybypassgraftsurgery |